The current investigation described the relationship between depression and outpatient medical utilization in a sample of
424 treatment-seeking individuals diagnosed with a depressive disorder and a demographically matched community sample of 424
men and women. This relationship was assessed longitudinally from baseline (intake for the patient sample) to 1-, 4-, and
10-year follow-ups. Patients and community individuals demonstrated distinct patterns of depressive symptoms and outpatient
medical utilization: patients declined in symptoms and medical utilization following treatment, although they continued to
have higher levels of depressive symptoms and outpatient utilization than controls at each follow-up period. Community controls
demonstrated no change from baseline in symptoms or utilization at any follow-up. Higher levels of depressive symptoms was
associated with increased outpatient medical utilization over the 10 years, even when age, sex, marital status, medical comorbidity,
and patient status were controlled. Results add further evidence for a relationship between symptoms of depression and outpatient
utilization by documenting this relationship in a posttreatment sample. Furthermore, the findings underscore the need for
long-term follow-ups in investigations of the association between treatment for depression and the outpatient medical utilization
of depressed individuals.
Preparation of this manuscript was supported in part by Department of Veterans Affairs Health Services Research and Development
Service and by NIMH Grant 1HSA410.
Rachel Kimerling, Ph.D., is now at the Department of Psychiatry, University of California at San Francisco School of Medicine.